Published • loading... • Updated
Drug-Resistant Fungus Cases Rise in Georgia, CDC Says
- Over 3,500 cases of the drug-resistant yeast Candida Auris have been reported across twenty-eight states this year, mostly in healthcare facilities.
- As of August 1, 3,544 clinical cases of Candida Auris have been reported to the U.S. Centers for Disease Control and Prevention, compared with 4,262 cases at the same time last year.
- Candida Auris is concerning because it is resistant to multiple antifungal drugs, making it difficult to treat.
- In the Southern United States, over 1,400 clinical cases have been reported, with Georgia recording 193 cases, ranking below Texas and Tennessee.
Insights by Ground AI
20 Articles
20 Articles
keenesentinel.com+16 Reposted by 16 other sources
New drug-resistant fungal disease increases among vulnerable patients
Twenty-eight states this year have reported over 3,500 cases of patients sick with the drug-resistant yeast candida auris, which can cause severe illness and is often reported in healthcare facilities.
Putting β-glucan testing into everyday practice for fungal infections
Invasive fungal infections are notoriously hard to catch early, and even harder to rule out with confidence. At the Parasitology-Mycology Laboratory of CHU Bordeaux, Consultant Physician Dr Frédéric Gabriel has spent years refining how his lab uses β-D-glucan (BDG) testing to sharpen that judgement call – including with the Wako β-glucan test. In this interview, he explains what the guidelines say, what actually happens at the bench, and where he sees the test heading next.
Coverage Details
Total News Sources20
Leaning Left16Leaning Right0Center2Last UpdatedBias Distribution89% Left
Bias Distribution
- 89% of the sources lean Left
89% Left
L 89%
11%
Factuality
To view factuality data please Upgrade to Premium
